SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

Stifel Nicolaus Maintains Buy on Dicerna Pharmaceuticals, Raises Price Target to $29

Stifel Nicolaus maintains Dicerna Pharmaceuticals (NASDAQ:DRNA) with a Buy and raises the price target from $25 to $29.

Benzinga · 02/28/2020 15:37

Stifel Nicolaus maintains Dicerna Pharmaceuticals (NASDAQ:DRNA) with a Buy and raises the price target from $25 to $29.